Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 9, 2000, Pages 2233-2241

  Poole, K ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; COMPLEMENT ACTIVATION; DRUG EFFECT; ENZYME SPECIFICITY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SHORT SURVEY;

ANTI-INFECTIVE AGENTS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; HUMANS;

EID: 0033836084     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.9.2233-2241.2000     Document Type: Short Survey

References (154)

1. Trends in bacterial resistance to fluoroquinolones
2. Mechanisms of quinolone resistance in clinical isolates of Shigella dysenteriae
3. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides
4. The mar regulon: Multiple resistance to antibiotics and other toxic chemicals
5. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
6. Multiple antibiotic resistance in Stenotrophomonas maltophilia
7. The genome sequence of Rickettsia prowazekii and the origin of mitochondria
8. Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes
9. Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvement of organic solvent tolerance of Escherichia coli K-12
10. The quinolones: History and overview
11. Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic
12. TolC of Escherichia coli functions as an outer membrane channel
13. The multidrug efflux protein Norm is a prototype of a new family of transporters
14. Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein
15. Chloramphenicol resistance in Pseudomonas cepacia because of decreased permeability
16. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance
17. Role of mutations in DNA gyrase genes in ciprofloxacin resistance of Pseudomonas aeruginosa susceptible or resistant to imipenem
18. Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa
19. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis
20. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni
21. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria
22. Endogenous active efflux of norfloxacin in susceptible Escherichia coli
23. Salicylate induction of antibiotic resistance in Escherichia coli: Activation of the mar operon and a mar-independent pathway
24. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistance (Mar) Escherichia coli selected by tetracycline resistance: Decreased drug accumulation asociated with membrane Changes in addition to OmpF reduction
25. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections
26. A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria
27. The effect of sodium salicylate on antibiotic susceptibility and synergy in Klebsiella pneumoniae
28. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition
29. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa
30. The MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa is growth-phase regulated
31. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals
32. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli
33. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO
34. NfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginose
35. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptibte Staphylococcus aureus
36. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae
37. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium
38. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones
39. The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon
40. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system
41. The bacterial outer membrane as a drug barrier
42. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa
43. Clinical applications of quinolones
44. Mechanisms of quinolone resistance in Escherichia coli: Characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation
45. Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJ
46. Interactions of dedicated export membrane proteins of the colicin V secretion system: CvaA, a member of the membrane fusion protein family, interacts with Cvab and TolC
47. New quinolone resistance in clinical isolates of Pseudomonas aeruginosa
48. Cloning of multidrug resistance gene pqrA from Proteus vulgaris
49. Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris
50. Drug resistance of Pseudomonas aeruginosa with special reference to new quinolones
51. Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa
52. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis
53. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa
54. Alignment and structure prediction of divergent protein families: Periplasmic and outer membrane proteins of bacterial efflux pumps
55. Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions
56. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli
57. Active efflux of organic solvents by Pseudomonas putida S12 is induced by solvents
58. Molecular analysis and nucleotide sequence of the envCD operon of Escherichia coli
59. Bacterial resistance to quinolones: Mechanisms and clinical implications
60. Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa
61. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa
62. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa
63. Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa
64. Bacterium genome sequence
65. Salmonella typhimurium acrB-like gene: Identification and role in resistance to biliary salts and detergents and in murine infection
66. Susceptibility of Xanthamonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro
67. Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin
68. The periplasmic murein peptide-binding protein MppA is a negative regulator of multiple antibiotic resistance in Escherichia coli
69. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa
70. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance
71. Interplay between the MexAB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa
72. Organic solvent-tolerant mutants of Pseudomonas aeruginosa display multiple antibiotic resistance
73. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa
74. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals
75. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli
76. Genes acrA and acrB encode a stress-induced system of Escherichia coli
77. Efflux pumps and drug resistance in Gram-negative bacteria
78. Porin alteration and active efflux: Two in vivo drug resistance strategies used by Enterobacter aerogenes
79. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli
80. Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains
81. Quinolone resistance from a transferable plasmid
82. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa
83. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa
84. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa
85. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli
86. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli
87. Resistance to pefloxacin in Pseudomonas aeruginosa
88. Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa
89. Active efflux of norfloxacin by Bacteroides fragilis
90. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: Roles of the mar and acrAB loci
91. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid
92. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei
93. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli
94. Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa
95. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii
96. The cobalt, zinc, and cadmium efflux system CzcABC from Alcaligenes eutrophus functions as a cation-proton antiporter in Escherichia coli
97. Outer membrane barrier as a mechanism of antimicrobial resistance
98. Antibiotic resistance caused by gram-negative multidrug efflux pumps
99. The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?
100. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those β-lactam antibiotics containing lipophilic side chains
101. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: Tetracyclines and fluoroquinolones as examples
102. Use of fluorescence probes to monitor function of the subunit proteins of the MexA-MexB-OprM drug extrusion machinery in Pseudomonas aeruginosa
103. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids
104. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump
105. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli
106. Cloning and nucleotide sequence of the Pseudomonas aeruginosa nfxB gene, conferring resistance to new quinolones
107. Cloning and characterization of a DNA fragment that complements the nfxB mutation in Pseudomonas aeruginosa PAO
108. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants
109. Major facilitator superfamily
110. Proton-dependent multidrug efflux systems
111. The SMR family: A novel family of multidrug efflux protein involved with the efflux of lipophilic drugs
112. Active efflux and diffusion are involved in transport of Pseudomonas aeraginosa cell-to-cell signals
113. A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa
114. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB multidrug resistant strains of Pseudomonas aeruginosa
115. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: Regulation by iron and possible involvement in the secretion of the siderophore pyoverdine
116. Multiple antibiotic resistance in Pseudomonas aeruginosa: Evidence for involvement of an efflux operon
117. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: MexR encodes a regulator of operon expression
118. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of β-lactam antibiotics: Mapping of chromosomal genes
119. Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin
120. Tetracycline resistance determinants: Mechanisms of action, regulation of expression, genetic mobility, and distribution
121. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO
122. Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport
123. NalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome
124. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump
125. Outer membrane permeability of non-typable Haemophilus influenzae
126. Selection of multiple antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes
127. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: Application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems
128. EnvC, a new lipoprotein of the cytoplasmic membrane of Escherichia coli
129. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Nesseria gonorrhoeae that are resistant to fecal lipids
130. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family
131. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain
132. The inner membrane efflux components are responsible for the β-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa
133. Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa
134. The Salmonella typhimurium mar locus: Molecular and genetic analyses and assessment of its role in virulence
135. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis
136. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: Analysis of the quinolone resistance acquisition
137. Active efflux of bile salts in Escherichia coli
138. The complete genome sequence of the gastric pathogen Helicobacter pylori
139. The ABC family of multidrug transporters in microorganisms
140. TolC, an Escherichia coli outer membrane protein required for hemolysin secretion
141. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability
142. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli
143. Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa
144. Function of the membrane fusion protein, MexA, of the MexAB-OprM efflux pump in Pseudomonas aeruginosa without an anchoring membrane
145. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa
146. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa
147. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa
148. AcrA is a highly asymmetric protein capable of spanning the periplasm
149. Bypassing the periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli
150. Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones
151. Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a multidrug efflux system
152. Influence of the TonB energy-coupling protein on efflux-mediated multidrug resistance in Pseudomonas aeruginosa
153. Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB
154. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM